About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT03448029

RECCORD (Recording Courses of Vascular Diseases) Registry

The RECording COurses of vasculaR Diseases registry (RECCORD registry) is an observational, prospective, multicentre, all-comers registry platform. In the initial phase, patients referred for endovas...

Lead sponsor: Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ulrich Hoffmann, Prof.

CONTACT

0049-30-20888831 info@reccord.de

Nasser Malyar, Dr.

CONTACT

Sponsors

Lead Sponsor

Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.

For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•any type of endovascular interventions for symptomatic PAD
•endovascular intervention for PAD of lower extremities, i.e. below the aorto-iliac bifurcation

Exclusion Criteria

•patients undergoing hybrid-(surgical and endovascular) and/or surgical interventions for symptomatic PAD
•patients with a life expectancy of \<6 months
•endovascular intervention for reasons other than symptomatic PAD

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

Natural History of Stroke: Cause and Development

NCT00009243 · Brain Disease, Ischemic Attack, Transient, and more

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 5, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment6,000

Start dateJan 2018

Last updatedFeb 5, 2021

Condition

Vascular Diseases Peripheral Artery Disease Claudication Critical Limb Ischemia Diabetic Foot

Locations shown

Klinikum der Ludwig-Maximilians Universität

München, Bavaria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 5, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions